Short answer · Medically reviewed summary · Last updated: 2026-05-08
Ameloblastoma is a rare, benign, but locally aggressive odontogenic tumor primarily affecting the jaw. While the term ameloblastoma is the current clinical standard, historical literature may refer to it as adamantinoma of the jaw, and it is classified under various subtypes in the WHO classification of head and neck tumors. Why does Ameloblastoma have multiple names? The nomenclature for ameloblastoma has evolved significantly over the last century as our understanding of its cellular origin changed.
Ameloblastoma is a rare, benign, but locally aggressive odontogenic tumor primarily affecting the jaw. While the term ameloblastoma is the current clinical standard, historical literature may refer to it as adamantinoma of the jaw, and it is classified under various subtypes in the WHO classification of head and neck tumors.
The nomenclature for ameloblastoma has evolved significantly over the last century as our understanding of its cellular origin changed. Historically, it was often confused with other bone tumors. The term "adamantinoma" was frequently used in older texts because the tumor cells resemble the enamel-producing cells (ameloblasts) found in developing teeth. As pathological classification became more rigorous, "ameloblastoma" became the preferred term to reflect its odontogenic epithelial nature.
When reviewing medical records or historical research papers, you may encounter several terms used to describe ameloblastoma:
In major global classification systems, ameloblastoma is categorized under the following identifiers to ensure consistency in research and clinical practice:
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.